Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ 198,942	$ 52	$ 612,025	$ (797)	$ (412,338)
Beginning balance, Shares at Dec. 31, 2022		52,099,211
Issuance of common stock in connection with public offering, net of issuance costs	117,346	$ 10	117,336
Issuance of common stock in connection with public offering, net of issuance costs, Shares		9,615,384
Issuance of common stock under employee benefit plans	348		348
Issuance of common stock under employee benefit plans, Shares		38,903
Vesting of restricted stock awards, Shares		5,496
Stock-based compensation expense	4,253		4,253
Unrealized gain (loss) on marketable securities	146			146
Net Income (Loss)	(24,779)				(24,779)
Ending balance at Mar. 31, 2023	296,256	$ 62	733,962	(651)	(437,117)
Ending balance, Shares at Mar. 31, 2023		61,758,994
Beginning balance at Dec. 31, 2022	198,942	$ 52	612,025	(797)	(412,338)
Beginning balance, Shares at Dec. 31, 2022		52,099,211
Unrealized gain (loss) on marketable securities	(403)
Net Income (Loss)	(48,562)
Ending balance at Jun. 30, 2023	275,428	$ 62	737,466	(1,200)	(460,900)
Ending balance, Shares at Jun. 30, 2023		61,822,554
Beginning balance at Dec. 31, 2022	198,942	$ 52	612,025	(797)	(412,338)
Beginning balance, Shares at Dec. 31, 2022		52,099,211
Ending balance at Dec. 31, 2023	235,193	$ 62	744,940	(136)	(509,673)
Ending balance, Shares at Dec. 31, 2023		61,915,367
Beginning balance at Mar. 31, 2023	296,256	$ 62	733,962	(651)	(437,117)
Beginning balance, Shares at Mar. 31, 2023		61,758,994
Issuance of common stock under employee benefit plans	141		141
Issuance of common stock under employee benefit plans, Shares		50,912
Vesting of restricted stock awards, Shares		12,648
Stock-based compensation expense	3,363		3,363
Unrealized gain (loss) on marketable securities	(549)			(549)
Net Income (Loss)	(23,783)				(23,783)
Ending balance at Jun. 30, 2023	275,428	$ 62	737,466	(1,200)	(460,900)
Ending balance, Shares at Jun. 30, 2023		61,822,554
Beginning balance at Dec. 31, 2023	235,193	$ 62	744,940	(136)	(509,673)
Beginning balance, Shares at Dec. 31, 2023		61,915,367
Issuance of common stock under employee benefit plans	1,651		1,651
Issuance of common stock under employee benefit plans, Shares		214,094
Vesting of restricted stock awards, Shares		11,550
Stock-based compensation expense	3,916		3,916
Unrealized gain (loss) on marketable securities	(298)			(298)
Net Income (Loss)	(26,870)				(26,870)
Ending balance at Mar. 31, 2024	213,592	$ 62	750,507	(434)	(536,543)
Ending balance, Shares at Mar. 31, 2024		62,141,011
Beginning balance at Dec. 31, 2023	235,193	$ 62	744,940	(136)	(509,673)
Beginning balance, Shares at Dec. 31, 2023		61,915,367
Unrealized gain (loss) on marketable securities	(230)
Net Income (Loss)	28,539
Ending balance at Jun. 30, 2024	273,790	$ 62	755,228	(366)	(481,134)
Ending balance, Shares at Jun. 30, 2024		62,250,631
Beginning balance at Mar. 31, 2024	213,592	$ 62	750,507	(434)	(536,543)
Beginning balance, Shares at Mar. 31, 2024		62,141,011
Issuance of common stock under employee benefit plans	377		377
Issuance of common stock under employee benefit plans, Shares		98,844
Vesting of restricted stock awards, Shares		10,776
Stock-based compensation expense	4,344		4,344
Unrealized gain (loss) on marketable securities	68			68
Net Income (Loss)	55,409				55,409
Ending balance at Jun. 30, 2024	$ 273,790	$ 62	$ 755,228	$ (366)	$ (481,134)
Ending balance, Shares at Jun. 30, 2024		62,250,631